Outset Medical (OM) Invested Capital (2018 - 2026)

Outset Medical (OM) has 9 years of Invested Capital data on file, last reported at $213.6 million in Q1 2026.

• Invested Capital for Q1 2026 came in at $213.6 million, down 20.96% year-over-year; the trailing twelve-month figure through Mar 2026 was $213.6 million (down 20.96% YoY), and the FY2025 annual result was $228.5 million, up 0.72% from the prior year.
• Invested Capital slipped to $213.6 million in Q1 2026 per OM's latest filing, from $228.5 million in the prior quarter.
• Over five years, Invested Capital peaked at $375.5 million in Q1 2022 and troughed at $213.6 million in Q1 2026.
• A 5-year average of $278.0 million and a median of $268.6 million in 2024 frame the typical range for Invested Capital.
• On a YoY basis, Invested Capital climbed as much as 11.53% in 2022 and fell as far as 29.71% in 2022.
• A 5-year view of Invested Capital shows it stood at $346.0 million in 2022, then retreated by 25.9% to $256.4 million in 2023, then slipped by 11.52% to $226.8 million in 2024, then grew by 0.72% to $228.5 million in 2025, then retreated by 6.51% to $213.6 million in 2026.
• Business Quant data shows OM's Invested Capital at $213.6 million in Q1 2026, $228.5 million in Q4 2025, and $243.5 million in Q3 2025.